0.5 ML tirzepatide 15 MG/ML Injection
- RxCUI
- 2644396
- RxNorm name
- 0.5 ML tirzepatide 15 MG/ML Injection
- Display name
- 0.5 ML tirzepatide 15 MG/ML Injection
- Full name
- 0.5 ML tirzepatide 15 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mounjaro | TIRZEPATIDE | Eli Lilly and Company | d2d7da5d-ad07-4228-955f-cf7e355c8cc0 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 2644396 |
| Zepbound | TIRZEPATIDE | Eli Lilly and Company | 487cd7e7-434c-4925-99fa-aa80b1cc776b | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 2644396 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 487cd7e7-434c-4925-99fa-aa80b1cc776b | tirzepatide 7.5 MG in 0.5 ML Injection [PSN] · 0.5 ML tirzepatide 15 MG/ML Injection [SCD] · tirzepatide 7.5 MG per 0.5 ML Injection [SY] | 3 | 38 | These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260422 |
| d2d7da5d-ad07-4228-955f-cf7e355c8cc0 | tirzepatide 7.5 MG in 0.5 ML Injection [PSN] · 0.5 ML tirzepatide 15 MG/ML Injection [SCD] · tirzepatide 7.5 MG per 0.5 ML Injection [SY] | 3 | 38 | These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260422 |